Global /Canada /Healthcare /Medical Devices /VERO
chevron_leftBack
Venus Concept Inc. logo

Venus Concept Inc.

VERO
NASDAQ: VERO Delayed
1.14USD -3.4%
As of 6 June 2026, Venus Concept Inc. has a market cap of $2.12M USD, ranking #47064 globally and #2435 in Canada. It ranks #4171 in the Healthcare sector, and #876 in the Medical Devices industry.
Global Rank
47064
Country Rank
2435
Sector Rank
4171
Industry Rank
876
Key Stats
Market Cap
$2.12MUSD
Enterprise Value
$30.6MUSD
Revenue (TTM)
$58.88MUSD
EBITDA (TTM)
-$30.89MUSD
Net Income (TTM)
-$54.61MUSD
EBITDA Margin
-52%
Profit Margin
-93%
PS Ratio
0.0
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Rajiv Kanishka De Silva open_in_new
Employees
292
Website
venus.ai open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.4% -10% -25% -46% -54% -70%

News

Loading...

VERO Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
VERO
Venus Concept Inc
ISIN: US92332W3034
Shares Out.:
1.859M1 Shares Float: 1.633M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
1.14 USD
OTC Markets
MIC: OTCM
VERO
Venus Concept Inc
ISIN: US92332W3034
TV:
SA:
YF:
GF:
BA:
MS:
0.3028 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Similar Companies

Industry: Medical Devices (Canada)
Name
Market Cap diff.
PE
BLCO
$5.47B
258K%
-
$290.28M
404.92M CAD
14K%
-
$238.87M
333.22M CAD
11K%
-
$64.23M
89.6M CAD
3K%
-
$37.42M
52.2M CAD
2K%
55.0
$31.69M
44.2M CAD
1K%
-
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
8M%
25.8
$160.73B
8M%
56.7
$159.07B
8M%
25.6
DHR
$126.55B
6M%
34.7
SYK
$120.69B
6M%
38.3
MDT
$101.9B
5M%
22.2
chevron_leftBack